GenePro SARS-CoV-2 Test kit is developed to enable high throughput analysis and flexibility in test numbers for a single run. It allows qualitative detection of Orf-1ab gene / E gene simultaneously. Orf-1ab gene has specific sequence from SARS-CoV-2 and E gene is common sequence within coronaviruses. The validity of RT-PCR reaction is confirmed by using RNA templete (SARS-CoV-2) as positive control.
Hayat Rapid Colorimetric & Fluorimetric One Step LAMP SARS-CoV-2 Test Kit
We have developed a Multiplex 2-target (N & E genes) direct RT-LAMP assay, without any need of RNA extraction. It has a very high sensitivity ( > 95%) with a fast (30 mins) and easy-to-read result. It works both colorimetric and fluorimetric.
Our price is very competitive ranging between 10 USD - 5 USD depending on order volume. The test has CE IVD mark and it is currently under review for NHS & FDA EUA. You can find more details on the attached presentation and IFU.
One Step Test for SARS-CoV-2 Antigen (Colloidal Gold) is intended for the qualitative detection of nucleocapsid protein antigen from SARS-in serum, plasma or whole blood samples from patients suspected of COVID-19 infection by a healthcare provider.
A kit contains:
Package specifications: 25 tests/box
1) Getein SARS-CoV-2 antigen test card in a sealed pouch with desiccant
2) Sample extraction solution: 25 tubes/box
3) Sampling swab: 25 pieces/box
4) Disposable pipette: 25 pieces/box
5) User manual: 1 piece/box
WONDFO SARS-CoV-2 Antibody test kits (Later Flow Method), Rapid response 15 minutes
- Easy to use, no equipment required
- Multiple sample types, including fingerstick blood
- Instant result in 15 minutes
- CE marked in vitro diagnostics for professional use in the EU
- Measuring IgG/IgM
- Specificity 99.57%
In Stock Now ready to ship or for inspection
10,000 Test Kits Stockholm
50,000 Test kits in Hong Kong
50,000 Test kits in Jakarta
The product is based on the principle of antigen-antibody reaction and immunoassay technique. The test device contains colloidal gold labeled SARS-CoV-2 recombinant protein, mouse-anti human IgG antibody immobilized in G test area, mouse-anti human IgM antibody immobilized in M test area and the corresponding antibody in quality control area (C).
During the test, when the SARS-CoV-2 IgM antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgM antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. The conjugates migrate upward through capillary effect and would be captured by mouse-anti human IgM antibody immobilized in M test area subsequently and this produces a purple-red band appears in the M test area. When the SARS-CoV-2 IgG antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgG antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. Theconjugates migrate upward through capillary effect and would be captured by mouse-anti human IgG antibody immobilized in G test area subsequently and this produces a purple-red band appears in the G test area. If it is a negative sample, there is not a purple-red band appeared in the M and G test area. Regardless of the presence or absence of the SARS-CoV-2 antibody in the sample, a purple-red band will appear in the quality control area (C). The purple-red band in the quality control area (C) is a criterion for judging whether there is enough sample and whether the chromatography process is normal. It also serves as the internal control standard for reagents.
SARS-CoV-2 IgG/IgM Rapid Test Kit
Intended Use: To detect IgM and IgG antibodies against N and S protein of SARS-CoV-2 in whole blood, serum and plasma
Product Format:Â 25 tests/kit
Kit Contents: test card, diluent, capillary, lancet, and instruction for use.
Storage/Stability: 2 C to 30C for 12 months.� eproducibility /Precision
100% Concordant across 3 lots with CV ±5%
Performance Comparison (A)
China Validation Test
Positive Samples 100 / 102
Sensitivity: 98.04%
Negative Samples 491/492
Specificity: 99.80%
Overall Accuracy: 99.49%
Performance Comparison (B)
Positive Samples 23 / 25
Sensitivity: 92%
Negative Samples 25 / 25
Specificity: 100%
Overall Accuracy: 96%
1. Nasopharynx swab specimen, non-invasive
2. Very simple to use
3. Convenient, no devices required
4. Rapid, results within 20 minutes
5. Cost-efficient
6:Listed on German BfArm ,got approval by PEI
Clinical report from local CDC
Sensitivity is 97.14%, Specificity is 100%, total accuracy rate is 99.68%.
Content of each kit: Test card (innovative and unique system), detailed instructions for use, sterile disposable swab, reactive solution for sample treatment, illustrative manual for use and operation.
General characteristics: CE self-diagnostic certification, holographic security label with individual code for authenticity verification, non-invasive, easy to use, no prescription required, rapid results in less than 15 minutes, high precision.
Sale restrictions: Exclusive sale to pharmacies, authorized companies, pharmaceutical distribution, socio-sanitary establishments, health establishments, occupational risk prevention, public organizations and health professionals.
Restricted sale to individuals. Sale subject to the provisions of Royal Decree 588/2021, of July 20, which modifies Royal Decree 1662/2000, of September 29, on medical devices for "in vitro" diagnosis, in order to regulate the sale to the public and the advertising of covid-19 self-diagnosis products. Sale subject in relation to tax matters to the provisions of Royal Legislative Decree 35/2020, of December 22, seventh final provision. Applicable tax rate of Value Added Tax to deliveries, imports and intra-community acquisitions of certain goods and provision of services necessary to combat the effects of SARS-CoV-2 as well as for the purposes of the special regime of the equivalence surcharge .
This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection.
This SARS-CoV-2 Ag Diagnostic Test Kit (Colloidal Gold) is intended for use by laypeople in the home environment. The application is carried out using saliva as a sample. - Patient-friendly - Saliva as a sample - User-friendly - simple and time-saving thanks to pre-filled sample tubes - Reliable - meets the valid requirements of the RKI and the BfArM and was evaluated by the Paul Ehrlich Institute PEI - Result within 15 minutes - All necessary materials in the pack contain specifications: - Colloidal gold immunoassay - Sensitivity: 95.51% (7 days after onset of symptoms) - Specificity: 99.45% - Sample material: saliva - Pack size: 1 test - Storage: 2 - 30 C - Shelf life: 18 months - Special approval for laypeople by the BfArM (BfArM GZ: 5640-S-032/21) - Specifications positively evaluated by the PEI (Paul-Ehrlich-Institut) Permitted users: Self-test for laypeople Scope of delivery per pack: 5x test cassette packed in foil pouch 5x sample tubes with extraction buffer 5x sterile disposable swabs 1x instructions for use 1x brief instruction
SARS-CoV-2 (COVID-19) infection has been declared a pandemic by WHO. Among the 7 qPCR protocols released by WHO, we chose USA-CDC protocol; however, our scientists quickly realized the risk of false-negative detection due to dimer-dimer problems in this protocol. So, we developed an optimized kit that overcame this problem. Unlike many other companies, we produce every single component of its kit by itself, reducing the risk of mistakes during production. Our qPCR kits have over 99% accuracy. SARS-CoV-2 qPCR Detection Kit also has a fully synthetic and non-pathogenic positive control which eliminates the possibility of false-negative results due to enzymatic problems.
The current test kit is based on specific antibody antigen reaction and immunoassay technique. The test card contains a gold labeled novel
coronavirus N protein monoclonal antibody p re coated on the binding pad
and a paired novel coronavirus N protein monoclonal antibodies fixed in the
test line (T) and corresponding antibodies in the quality control line (C).
During the test, the N protein in the specimen binds to the gold-labeled nove lcoronavirus N protein antibody pre-coated on the binding pad, and the
conjugate moves upward under the capillary effect, and then is trapped by N
protein monoclonal antibody conjugate fixed in the Test Line (T). The higher
the N protein content in the specimen, the more conjugates are trapped, and
the darker the color of the Test Line (T). If there is no novel coronavirus in
the specimen or the virus content is below the detection limit, no colour
appears in the Test Line (T). A purple red band will app ear in the Control
Line (C) regardless of whether there is a virus in the specimen. The
purple red band that appears in the Control Line (C) is the criteria for
determining whether there is enough specimen and whether the
chromatography process is normal.
Cat No : 09N77-095. The Abbott RealTime SARS-C0V-2 assay is an Emergency Use Authorization (EUA) test authorized by the U.S. FDA for use by authorized laboratories, using real-time (RT) polymerase chain reaction (PCR) technology for the qualitative detection of nucleic acids from the SARS-CoV-2 virus and diagnosis of SARS-CoV-2 virus infection from individuals meeting CDC clinical and/or epidemiological testing criteria.
The FlowFlex Rapid Antigen Test uses the latest patented technology to detect proteins in nasal samples, ensuring that it can detect all strains of the COVID-19 virus within just 15 minutes. Using a simple nasal swab with 2cm of the nose - it makes it extremely easy to personally administer an accurate lateral flow test without medical supervision.
Each individually packaged kit comes complete with:
1 x Test Cassette
1 x Extraction Buffer Tube with Reagent
1 x Disposable Swab
1 x Waste Bag
1 x Package Insert
PocRoc SARS-CoV-2 Antigen Rapid Test Kit (TRFIA) is intended for qualitative
detection of SARS-CoV-2 nucleocapsid antigen from NS specimen or VTM sample
without guanidine
The lab indicated that the recombinant protein of Indian mutant (B.1.617.2),
A.23.1(Unit Kingdom), AT.1 (Russia), B.1.1.7(Unit Kingdom), B.1.351 (South Africa),
B.1.616 (France), B.1.621 (Colombia), C.36 (Egypt), C.37 (Peru), P.1 (Japan/Brazil),
P.2 (Brazil) can be detected by Jinwofu SARS-CoV-2 Antigen Test Kit.
For the newly descovered mutant Omicron(B.1.1.529), we performed sequence
alignment analysis on its mutation sites, and found that all the mutation sites were
outside the epitope region recognized by the monoclonal antibody selected by our company.
By bioinformatics analysis, Jinwofu SARS-CoV-2 Antigen Test Kit can also effectively detect
mutant Omicron(B.1.1529)
21561 Sars Cov 2 Test Kit Suppliers
Short on time? Let Sars Cov 2 Test Kit sellers contact you.
